Loading...
XSHG
600998
Market cap3.72bUSD
Jul 09, Last price  
5.00CNY
1D
-0.20%
1Q
-6.72%
Jan 2017
-49.70%
IPO
-40.33%
Name

Jointown Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHG:600998 chart
P/E
11.18
P/S
0.16
EPS
0.45
Div Yield, %
4.00%
Shrs. gr., 5y
-0.81%
Rev. gr., 5y
7.80%
Revenues
161.39b
+6.31%
13,048,102,60516,287,598,13618,957,708,89521,251,772,76424,838,678,87529,507,662,75633,438,049,66541,068,404,47849,589,246,31161,556,839,88573,942,894,40287,136,358,55399,497,077,000110,859,514,087122,407,434,022140,424,192,000150,139,847,000151,809,798,857161,389,993,000
Net income
2.25b
-10.07%
159,783,448202,635,778297,891,827359,543,527374,134,158412,720,763477,927,817560,706,763694,534,910876,741,8201,445,510,1071,340,578,8301,726,549,0003,075,054,8282,448,334,1872,084,963,0002,174,043,0002,507,391,9532,254,864,000
CFO
3.44b
+11.62%
65,952,703494,748,8270000138,468,5820435,955,993431,263,75201,222,023,1642,767,873,0483,443,884,1083,459,045,0573,986,228,1564,782,206,8203,082,502,0723,440,654,842
Dividend
Jun 17, 20250.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.
IPO date
Nov 02, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT